Microbio Co

Microbio Co Gross Margin

The Gross Margin of Microbio Co (4128.TWO) as of Oct 20, 2026 is 39.78 %. In the previous year, Gross Margin was 39.24 % — a change of 1.37% (higher).

Gross Margin

39.78 %

YoY

1.37%

Last updated:

Gross Margin of Microbio Co is 2025 39.78 % . Gross Margin of Microbio Co was 2024 39.24 % . It decreases by 1.37% higher compared to the previous year.

Microbio Co's gross margin stands at 39.8%, down from 41.5% several years earlier.

The Microbio Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
39.39 TWD
Jan 1, 2019
39.56 TWD
Jan 1, 2020
39.57 TWD
Jan 1, 2021
41.49 TWD
Jan 1, 2022
40.15 TWD
Jan 1, 2023
23.90 TWD
Jan 1, 2024
39.24 TWD
Jan 1, 2025
39.78 TWD
The Microbio Co Gross Margin history
YEARGross MarginYoY
39.78 %+1.37%
39.24 %+64.16%
23.90 %-40.46%
40.15 %-3.23%
41.49 %+4.84%
39.57 %+0.04%
39.56 %+0.43%
39.39 %+6.83%
36.87 %-3.35%
38.15 %+0.73%
37.87 %-7.03%
40.74 %+10,213.33%
0.39 %-8.25%
0.43 %-14.05%
0.50 %-2.94%
0.52 %+14.67%
0.45 %+2.45%
0.44 %-5.13%
0.46 %+3.21%
0.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Microbio Co stock

Gross Margin of Microbio Co is 39.78 % in 2025.

Gross Margin of Microbio Co changed from 39.24 % to 39.78 %, representing a 1.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Microbio Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Microbio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Microbio Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Microbio Co